A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

Clinical trial NCT00432562 · COMPLETED

Trial details

NCT number: NCT00432562
Sponsor: Mast Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Non-small Cell Lung Cancer Non-Hodgkins Lymphoma

Start date: 2007-02-01
Primary completion: 2007-11-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.